Cimzia is a prescription medication used to treat certain autoimmune diseases, including Crohn’s disease and rheumatoid arthritis. But who makes this powerful medication? In this article, we’ll explore the manufacturer behind Cimzia and how it helps those suffering from autoimmune diseases find relief.
Cimzia is a prescription drug manufactured by UCB, a Belgian-based biopharmaceutical company. It is used to treat rheumatoid arthritis, Crohn’s disease, psoriasis, and ulcerative colitis. UCB is a global biopharmaceutical company dedicated to the research, development, and commercialization of innovative therapies for people living with severe diseases of the immune system or of the central nervous system. It has operations in more than 40 countries and employs around 8,500 people worldwide.
Who Makes Cimzia?
Cimzia is a prescription medication used to treat certain autoimmune disorders, including rheumatoid arthritis, Crohn’s Disease, and plaque psoriasis. Cimzia is manufactured by UCB, a biopharmaceutical company based in Brussels, Belgium.
History of UCB
UCB was founded in 1928 as a specialty chemical company. Over the years, the company grew and expanded its operations to include research, development, and manufacturing of pharmaceuticals and biopharmaceuticals. UCB has become a leader in the development of treatments for diseases such as epilepsy, Parkinson’s disease, and multiple sclerosis.
UCB’s Focus on Autoimmune Diseases
UCB has a strong focus on developing treatments for autoimmune diseases. Cimzia is a biologic drug approved by the FDA for the treatment of rheumatoid arthritis, Crohn’s disease, and plaque psoriasis. The drug is also being studied for use in other autoimmune conditions such as ulcerative colitis, lupus, and ankylosing spondylitis.
The Cimzia Manufacturing Process
UCB manufactures Cimzia at its facility in Belgium. The drug is produced using a recombinant DNA technology, which involves the insertion of a gene into a bacterial strain to produce an active ingredient. The drug is then purified and filled into prefilled syringes for patient use.
Conclusion
UCB is a biopharmaceutical company based in Brussels, Belgium. The company has a focus on developing treatments for autoimmune diseases, and Cimzia is one of its products. Cimzia is manufactured at UCB’s facility in Belgium using a recombinant DNA technology.
Frequently Asked Questions
1. Who makes Cimzia?
Cimzia is a prescription medication used to treat certain inflammatory conditions, such as Crohn’s disease and psoriatic arthritis. It is manufactured by UCB Inc., an international biopharmaceutical company headquartered in Brussels, Belgium. UCB Inc. is a global leader in the research, development, and marketing of innovative medicines for people with severe diseases of the immune system, the central nervous system, and other targeted conditions.
2. How does Cimzia work?
Cimzia is a biologic medication, which means it is made from living cells. Specifically, it is a human monoclonal antibody that blocks the action of the cytokine tumor necrosis factor (TNF). TNF is a naturally occurring cytokine produced by the immune system that plays an important role in causing inflammation. By blocking the action of TNF, Cimzia helps reduce inflammation and the symptoms associated with it.
3. What conditions is Cimzia used to treat?
Cimzia is approved by the U.S. Food and Drug Administration (FDA) to treat adult patients with Crohn’s disease, psoriatic arthritis, rheumatoid arthritis, and ankylosing spondylitis. It is also used to treat adults with plaque psoriasis who are candidates for systemic therapy or phototherapy.
4. What are the side effects of Cimzia?
Common side effects of Cimzia include injection site reactions, upper respiratory tract infections, headaches, and abdominal pain. Other less common side effects can include serious infections, anemia, liver problems, and changes in certain laboratory tests. It is important to discuss any potential side effects with your doctor before taking Cimzia.
5. How is Cimzia administered?
Cimzia is administered via subcutaneous injection. This means that the medication is injected just under the skin, usually in the thigh, abdomen, or upper arm. It is important to follow your doctor’s instructions for the dosing and administration of Cimzia.
6. What should I do if I miss a dose of Cimzia?
If you miss a dose of Cimzia, it is important to contact your healthcare provider as soon as possible. Depending on the instructions given by your healthcare provider, you may be able to take the missed dose as soon as possible, or you may be advised to wait until your next scheduled dose. It is important not to take a double dose of Cimzia.
Cimzia is an innovative and effective biologic therapy that has been approved by the US Food and Drug Administration to help treat Crohn’s disease and other chronic inflammatory conditions. Developed by UCB, with over a century of experience in research and development, Cimzia offers a safe, effective and convenient solution to treat inflammation and reduce long-term side effects. With its long-term safety and efficacy, Cimzia is helping to improve the lives of many people living with chronic inflammation.